Eglen, Richard M.

Three-Dimensional Cell Cultures in Drug Discovery and Development

Fang, Y., & Eglen, R. M. (2017) · SLAS Discovery

3D Printing in Biomedical ResearchTissue Engineering and Regenerative Medicine

Cited by 849

Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development

Wess, J., Eglen, R. M., & Gautam, D. (2007) · Nature Reviews Drug Discovery

Receptor Mechanisms and SignalingNeuroscience and Neuropharmacology Research

Cited by 637

Pharmacological characterization of two novel and potent 5‐HT4receptor agonists, RS 67333 and RS 67506,in vitro and in vivo

Eglen, R. M., Bonhaus, D. W., Johnson, L. G., Leung, E., & Clark, R. D. (1995) · British Journal of Pharmacology

Receptor Mechanisms and SignalingNeurotransmitter Receptor Influence on Behavior

Cited by 102

Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening

Eglen, R., & Reisine, T. (2011) · ASSAY and Drug Development Technologies

Pluripotent Stem Cells ResearchAnimal testing and alternatives

Cited by 100

The Use of Immortalized Cell Lines in GPCR Screening: The Good, Bad and Ugly.

Eglen, R., Gilchrist, A., & Reisine, T. (2008) · Combinatorial Chemistry & High Throughput Screening

Receptor Mechanisms and SignalingComputational Drug Discovery Methods

Cited by 36